Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies

Cardiovascular Research

Volumn 79, Issue 1, 2008, Pages 109-117

  Lombardi, Raffaella ^a   Bell, Achim ^a   Senthil, Vinitha ^a   Sidhu, Jasvinder ^c   Noseda, Michela ^c   Roberts, Robert ^d   Marian, Ali J ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b TEXAS HEART INSTITUTE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Cardiomyopathy; Fibrosis; Genetics; Heart failure; Mouse model; Mutation; Pathogenesis

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA ACTIN; ALPHA TROPOMYOSIN; ANTIBODY; MUSCLE PROTEIN; PROTEIN; TROPONIN C; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GENE MUTATION; HEART DILATATION; HEART VENTRICLE; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SYSTOLE; THIN FILAMENT;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CALCIUM; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; HEART VENTRICLES; HYPERTROPHY, LEFT VENTRICULAR; MICE; MICE, TRANSGENIC; MUTATION; NATRIURETIC PEPTIDE, C-TYPE; PHENOTYPE; PROTEIN PRECURSORS; SARCOMERES; TROPONIN T;

EID: 45849084951     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn078     Document Type: Article

References (29)

1. Marian AJ. Clinical and molecular genetic aspects of hypertrophic cardiomyopathy. Curr Cardiol Rev 2005;1:53-63.
2. Burkett EL, Hershberger RE. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol 2005;45:969-981.
3. Marian AJ. Phenotypic plasticity of sarcomeric protein mutations. J Am Coll Cardiol 2007;49:2427-2429.
4. Capell BC, Collins FS. Human laminopathies: nuclei gone genetically awry. Nat Rev Genet 2006;7:940-952.
5. Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE et al. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 1990;62:999-1006.
6. Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000;343:1688-1696.
7. Thierfelder L, Watkins H, MacRae C, Lamas R, McKennaW, Vosberg HP et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994;77:701-712.
8. Li D, Czernuszewicz GZ, Gonzalez O, Tapscott T, Karibe A, Durand JB et al. Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation 2001;104:2188-2193.
9. Lim DS, Lutucuta S, Bachireddy P, Youker K, Evans A, Entman M et al. Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation 2001;103:789-791.
10. Solaro RJ, Varghese J, Marian AJ, Chandra M. Molecular mechanisms of cardiac myofilament activation: modulation by pH and a troponin T mutant R92Q. Basic Res Cardiol 2002;97(Suppl. 1):I102-I110.
11. Tsybouleva N, Zhang L, Chen SN, Patel R, Lutucuta S, Nemoto S et al. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation 2004;109:1284-1291.
12. Subramaniam A, Gulick J, Neumann J, Knotts S, Robbins J. Transgenic analysis of the thyroid-responsive elements in the alpha-cardiac myosin heavy chain gene promoter. J Biol Chem 1993;268:4331-4336.
13. Lutucuta S, Tsybouleva N, Ishiyama M, DeFreitas G, Wei L, Carabello B et al. Induction and reversal of cardiac phenotype of human hypertrophic cardiomyopathy mutation cardiac troponin T-Q92 in switch on-switch off bigenic mice. J Am Coll Cardiol 2004;44:2221-2230.
14. Garcia-Gras E, Lombardi R, Giphart MJ, Willerson JT, Schneider MD, Khoury DS et al. Suppression of canonical Wnt/catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right centricular cardiomyopathy. J Clin Invest 2006;116:2012-2021.
15. Marian AJ, Senthil V, Chen SN, Lombardi R. Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation. J Am Coll Cardiol 2006;47:827-834.
16. Solaro RJ, Pang DC, Briggs FN. The purification of cardiac myofibrils with Triton X-100. Biochim Biophys Acta 1971;245:259-262.
17. Nagueh SF, Chen S, Patel R, Tsybouleva N, Lutucuta S, Kopelen HA et al. Evolution of expression of cardiac phenotypes over a 4-year period in the b-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy. J Mol and Cell Cardiol 2004;36:663-673.
18. Senthil V, Chen SN, Tsybouleva N, Halder T, Nagueh SF, Willerson JT et al. Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circ Res 2005;97:285-292.
19. Oberst L, Zhao G, Park JT, Brugada R, Michael LH, Entman ML et al. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. J Clin Invest 1998;102:1498-1505.
20. Lu QW, Morimoto S, Harada K, Du CK, Takahashi-Yanaga F, Miwa Y et al. Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization. J Mol Cell Cardiol 2003;35:1421-1427.
21. Venkatraman G, Harada K, Gomes AV, Kerrick GW, Potter JD. Different functional properties of Troponin T mutants that cause dilated cardiomyopathy. J Biol Chem 2003;278:41670-41676.
22. Morimoto S, Yanaga F, Minakami R, Ohtsuki I. Ca2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy. Am J Physiol 1998;275:C200-C207.
23. Yanaga F, Morimoto S, Ohtsuki I. Ca2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy. J Biol Chem 1999;274:8806-8812.
24. Robinson P, Griffiths PJ, Watkins H, Redwood CS. Dilated and hypertrophic cardiomyopathy mutations in troponin and α-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments. Circ Res 2007;101:1266-1273.
25. Haim TE, Dowell C, Diamanti T, Scheuer J, Tardiff JC. Independent FHC-related cardiac troponin T mutations exhibit specific alterations in myocellular contractility and calcium kinetics. J Mol Cell Cardiol 2007;42:1098-1110.
26. Sirenko SG, Potter JD, Knollmann BC. Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts - role of myofilament Ca2+ sensitivity increase. J Physiol (London) 2006;575:201-213.
27. He H, Javadpour MM, Latif F, Tardiff JC, Ingwall JS. R-92L and R-92W mutations in cardiac troponin T lead to distinct energetic phenotypes in intact mouse hearts. Biophys J 2007;93:1834-1844.
28. Tardiff JC, Hewett TE, Palmer BM, Olsson C, Factor SM, Moore RL et al. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest 1999;104:469-481.
29. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;332:1058-1064.